Last updated on November 2017

Clinical trial for Patients with leukemia or lymphoma MI-CP204 (The Blood Cancer Study)


Brief description of study

Clinical trial for Patients with leukemia or lymphoma MI-CP204 (The Blood Cancer Study)

Detailed Study Description

This clinical trial is provided by TrialReach.

If you have a B-cell malignancy (leukemia or lymphoma) you may be eligible to take part in this clinical research study. We are looking for people with leukemia or lymphoma that has returned after initial successful treatment (relapsed) or hasn’t improved with treatment (refractory). It can be difficult for patients with refractory or relapsed B-cell malignancies to find treatments that work well for them, which is why we need to research potential new medications.

Clinical Study Identifier: TX6637

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )